Literature DB >> 22691243

Effect of weight reduction on leptin, total ghrelin and obestatin concentrations in prepubertal children.

T Arrigo1, E Gitto, V Ferraù, C Munafò, A Alibrandi, G L Marseglia, A Salpietro, M Miraglia Del Giudice, S Leonardi, G Ciprandi, C Salpietro.   

Abstract

The aim of the study was to evaluate fasting levels of glucose, insulin, leptin, total ghrelin, and obestatin in a group of prepubescent obese children before and after weight loss. We enrolled 64 prepubescent obese children, but only 35 completed the study (mean age 7.6 +- 0.9 years, 19 females) and 20 normal-weight prepubescent children as controls. Fasting plasma concentration of glucose, insulin, Homeostasis Model assessment for insulin resistance (HOMA-IR), and leptin, total ghrelin, and obestatin levels were measured at baseline and after a 6-month lifestyle intervention (i.e. improved nutrition and increased physical activity). At baseline, obese children showed significantly (p less than 0.001) higher leptin and obestatin levels, and lower total ghrelin concentrations than control subjects. Weight loss significantly (p less than 0.001) diminished plasma leptin and insulin levels and increased ghrelin and obestatin concentrations. Weight loss in prepubescent children is associated with a significant change in leptin, ghrelin and obestatin concentrations. These results confirm the hypothesis that levels of these hormones are closely associated with obesity in childhood and might take part, as consequence but not as a cause, in glucose, fat, and energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691243

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  5 in total

1.  Evaluation of serum xenin and ghrelin levels and their relationship with nonalcoholic fatty liver disease and insulin resistance in obese adolescents.

Authors:  N Arslan; O Sayin; Y Tokgoz
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

Review 2.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

Review 3.  Recent advances on diagnosis and management of childhood asthma and food allergies.

Authors:  Dani Hakimeh; Salvatore Tripodi
Journal:  Ital J Pediatr       Date:  2013-12-27       Impact factor: 2.638

Review 4.  Portal hypertension as immune mediate disease.

Authors:  Sara Manti; Lucia Marseglia; Gabriella D'Angelo; Martina Filippelli; Caterina Cuppari; Eloisa Gitto; Claudio Romano; Teresa Arrigo; Carmelo Salpietro
Journal:  Hepat Mon       Date:  2014-06-07       Impact factor: 0.660

5.  Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.

Authors:  M P van der Aa; M A J Elst; E M W van de Garde; E G A H van Mil; C A J Knibbe; M M J van der Vorst
Journal:  Nutr Diabetes       Date:  2016-08-29       Impact factor: 5.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.